# OnCo record primus-001 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/primus-001/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "primus-001", "NCT04151277" ;
  schema:name "PRIMUS 001"@en ;
  schema:alternateName "PRIMUS-001"@en, "PRIMUS001"@en, "Precision-Panc PRIMUS 001"@en ;
  schema:description "PRIMUS 001 is the flagship trial of the UK Precision-Panc programme, comparing a new oxaliplatin, fluorouracil and nab-paclitaxel combination with standard nab-paclitaxel and gemcitabine at 30 NHS hospitals from Aberdeen to Plymouth while collecting tumour DNA to find who benefits from which chemotherapy."@en ;
  schema:url <https://onco.cc/trials/primus-001/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04151277>, <https://www.isrctn.com/ISRCTN75002153> ;
  onco:status "active" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/metastatic-pdac/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/cgp/> ;
  onco:drugs <https://onco.cc/drugs/folfox/>, <https://onco.cc/drugs/nab-paclitaxel/>, <https://onco.cc/drugs/gemcitabine-nab-paclitaxel/> ;
  onco:institutions <https://onco.cc/institutions/cruk/> ;
  onco:terms <https://onco.cc/terms/pancreatic-trials-open-today/> .